Pharma   40.73%
Services   29.60%
Medtech   10.14%
Diagnostics   8.85%
Biotech   3.29%
Generics   2.19%
Europe   53.05%
EM Asia   22.92%
Nordamerika   8.05%
EM Europe   3.89%
Asien   3.61%
EM Rest World   3.27%